Literature DB >> 27639924

Should refractory Kawasaki disease be considered occult macrophage activation syndrome?

Ui-Yoon Choi1, Seung-Beom Han1, Soo-Young Lee2, Dae-Chul Jeong1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27639924     DOI： 10.1016/j.semarthrit.2016.08.007

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN： 0049-0172            Impact factor:   5.532


× No keyword cloud information.
  2 in total

1.  High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant.

Authors:  Marie Lind-Holst; Ulla Birgitte Hartling; Anne Estmann Christensen
Journal:  BMJ Case Rep       Date:  2019-08-04

2.  Severe Recurrent Fever Episodes With Clinical Diagnosis of Hemophagocytic Lymphohistiocytosis, Incomplete Kawasaki Disease and Systemic-Onset Juvenile Idiopathic Arthritis: A Case Report and Literature Review.

Authors:  Hongkun Jiang; Zhiliang Yang
Journal:  Front Pediatr       Date:  2020-03-10       Impact factor: 3.418
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.